Tyla Kicks Off A*POP World Tour in Paris With Royal MusiQ Along for the Ride

South African Grammy Award-winning artist Tyla has officially opened her A*POP World Tour in Paris, France, in what promises to be a landmark moment for South African music on the international stage. The tour launch, confirmed on 13 October 2026, represents one of the most high-profile global concert campaigns ever undertaken by a South African artist, and the choice of Paris as the opening city underscores Tyla's standing as a genuinely international star.

Adding further local flavour to the European dates is the news that Royal MusiQ — the South African Amapiano act — has been confirmed to join the tour for its European stretch. This pairing brings together two distinct but complementary strands of contemporary South African sound: Tyla's polished, genre-blending Afropop aesthetic and Royal MusiQ's roots in the Amapiano movement that has itself captured global attention in recent years. The combination is likely to resonate strongly with European audiences who have shown growing appetite for music from the African continent.

The A*POP World Tour is notable not only for its scale but for what it signals about the current moment in South African popular music. Over the past few years, South African artists have steadily broken into mainstream international markets, with Amapiano in particular finding audiences across the United Kingdom, Europe, and beyond. Tyla's tour — and the inclusion of Royal MusiQ — suggests that this is no longer a niche cultural export but a sustainable, commercially viable presence on the world stage.

For Tyla, the Paris opener is the culmination of a meteoric rise that has seen her move from being a celebrated domestic talent to a genuinely global name. Her crossover success has been built on a sound that draws from South African musical traditions while incorporating international pop sensibilities, making her work accessible to listeners who may have had little prior exposure to South African music. A world tour of this nature cements her position at the forefront of that cultural bridge-building.

Royal MusiQ's inclusion in the European dates is significant in its own right. While Amapiano has attracted considerable international media coverage and has been embraced by DJs and producers worldwide, the opportunity to perform as part of a major world tour provides a platform that goes well beyond festival appearances or streaming numbers. Touring alongside an artist of Tyla's profile gives Royal MusiQ direct access to large, varied audiences across multiple European cities, which could meaningfully accelerate the act's international profile.

For South African music fans, the news will likely spark considerable pride and anticipation. South Africa has long produced world-class musical talent, but the infrastructure and industry connections needed to translate domestic success into sustained international touring have historically been difficult to secure. The A*POP World Tour, with its Paris launch and European itinerary, suggests that those barriers are becoming more navigable — at least for artists operating at the highest level.

What remains unclear from the available information is the full list of cities included in the European leg, the precise dates on which Royal MusiQ will perform, and details about the broader world tour schedule beyond Europe. It is also not yet known whether additional South African artists might join other legs of the tour as it extends to further regions. These are details that fans and industry watchers will be eager to learn as more information is released.

What is certain is that the opening night in Paris represents a moment worth watching closely. South African music's global story is still being written, and the A*POP World Tour — with Tyla at the helm and Royal MusiQ in support — appears to be one of its most compelling chapters yet. Readers should keep an eye on further announcements regarding the tour's full schedule and any additional South African acts that may be confirmed for future dates.